Joint utilisation of medications to block platelets optimally - JUMBO-TIMI 26

Description:

The goal of the trial was to evaluate the safety of the novel thienopyridine P2Y12 antagonist prasugrel compared with clopidogrel among patients undergoing elective or urgent percutaneous coronary intervention (PCI) with intended coronary stenting.